Short-course sublingual immunotherapy by mucoadhesive patch and tolerogenic particle enhanced allergen presentation
Language English Country England, Great Britain Media print-electronic
Document type Letter, Research Support, Non-U.S. Gov't
Grant support
CZ.02.1.01/0.0/0.0/16_019/0000843
Hybrid Materials for Hierarchical Structures
CEREBIT CZ.02.1/0.0/0.0/16_025/0007397
The Czech Ministry of Education, Youth and Sports OPVVV PO1 projects "FIT"
CZ.02.1.01/0.0/0.0/15_003/0000495
The Czech Ministry of Education, Youth and Sports OPVVV PO1 projects "FIT"
827234 - SOMIT
EU Horizon 2020 SME Phase 1
PubMed
33682209
DOI
10.1111/cea.13862
Knihovny.cz E-resources
- Keywords
- food allergy, immunotherapy and tolerance induction, next-generation AIT,
- MeSH
- Allergens administration & dosage immunology MeSH
- Administration, Mucosal MeSH
- Immune Tolerance MeSH
- Drug Delivery Systems MeSH
- Ovalbumin administration & dosage immunology MeSH
- Swine MeSH
- Sublingual Immunotherapy methods MeSH
- Mouth Floor MeSH
- Animals MeSH
- Check Tag
- Animals MeSH
- Publication type
- Letter MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Allergens MeSH
- Ovalbumin MeSH
Allero Therapeutics BV Rotterdam Netherlands
Department of Biomedicine Aarhus University Aarhus Denmark
Department of Pharmacology and Immunotherapy Veterinary Research Institute Brno Czech Republic
See more in PubMed
Hoffmann HJ, Valovirta E, Pfaar O, et al. Novel approaches and perspectives in allergen immunotherapy. Allergy. 2017;72:1022-1034.
Sampath V, Sindher SB, Zhang W, Nadeau KC. New treatment directions in food allergy. Ann Allergy Asthma Immunol. 2018;120:254-262.
Novak N, Haberstok J, Bieber T, Allam JP. The immune privilege of the oral mucosa. Trends Mol Med. 2008;14:191-198.
Kiel MA, Röder E, Gerth van Wijk R, Al MJ, Hop Wim CJ, Rutten-van Mölken MPMH. Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy. J Allergy Clin Immunol. 2013;132:353-360.
Moingeon P. Update on immune mechanisms associated with sublingual immunotherapy: practical implications for the clinician. J Allergy Clin Immunol Pract. 2013;1:228-241.
Van Braeckel-Budimir N, Haijema BJ, Leenhouts K. Bacterium-like particles for efficient immune stimulation of existing vaccines and new subunit vaccines in mucosal applications. Front Immunol. 2013;4:282.
Mašek J, Lubasová D, Lukáč R, et al. Multi-layered nanofibrous mucoadhesive films for buccal and sublingual administration of drug-delivery and vaccination nanoparticles - important step towards effective mucosal vaccines. J Control Release. 2017;249:183-195.
Thirion-Delalande C, Gervais F, Fisch C, et al. Comparative analysis of the oral mucosae from rodents and non-rodents: Application to the nonclinical evaluation of sublingual immunotherapy products. PLoS One. 2017;12:e0183398.
Rupa P, Hamilton K, Cirinna M, Wilkie BN. A neonatal swine model of allergy induced by the major food allergen chicken ovomucoid (Gal d 1). Int Arch Allergy Immunol. 2008;146:11-18.
Fleischer DM, Burks AW, Vickery BP, et al. Sublingual immunotherapy for peanut allergy: a randomized, double-blind, placebo-controlled multicenter trial. J Allergy Clin Immunol. 2013;131:119-127.
Barker-Tejeda TC, Bazire R, Obeso D, et al. Exploring novel systemic biomarker approaches in grass-pollen sublingual immunotherapy using omics. Allergy. 2020.https://doi.org/10.1111/all.14565. [Epub ahead of print].
